Skip to main content
. 2012 Dec 14;12:1078. doi: 10.1186/1471-2458-12-1078

Table 2.

Measures used at the screening phase (2001–06) and at the health assessment (2009–11) in the ADDITION-PRO study

  Screening phase: low risk1 participants Screening phase: high risk2 participants ADDITION-PRO health assessment
Danish risk score questionnaire
 X
 X
 X
Socio-demographic variables
Age
 X
 X
 X
Sex
 X
 X
 X
Biochemistry
Random capillary blood glucose
  
 X
  
Fasting capillary blood glucose3
  
 X
  
Venous glycated haemoglobin (HbA1c)
  
 X
 X
75 g oral glucose tolerance test3,4
  
 X
 X
Insulin
  
  
 X
Total cholesterol
  
 X
 X
LDL-cholesterol
  
 X
 X
HDL-cholesterol
  
 X
 X
Triglycerides
  
 X
 X
Plasma and urine creatinine3
  
 X
 X
Urine albumin3
  
 X
 X
DNA3
  
 X
 X
Alanine transaminase
  
  
 X
Alkaline phosphatase
  
  
 X
Biobank: plasma, serum, spot urine3
  
 X
 X
Whole saliva5
  
  
 X
Clinical measures
Electrocardiogram
  
  
 X
Heart rate
  
  
 X
Brachial blood pressure
  
 X
 X
Central blood pressure
  
  
 X
Aortic pulse wave velocity
  
  
 X
Advanced glycation end-products
  
  
 X
Anthropometric variables
Height
  
 X
 X
Weight
  
 X
 X
Waist circumference
  
 X
 X
Hip circumference
  
 X
 X
Body fat percentage
  
  
 X
Abdominal fat distribution by ultrasound6
  
  
 X
Hepatic fat content by ultrasound6
  
  
 X
Physical activity
Combined accelerometer and heart rate monitor (ActiHeart)
  
  
 X
Recent physical activity questionnaire (RPAQ)
  
  
 X
Sleep questionnaire7
  
  
 X
Questionnaire measures
Ethnicity / nationality
  
 X
  
Education
  
 X
  
Occupation
  
 X
 X
Personal medical history
  
 X
 X
Family history of diabetes
 X
 X
 X
Family history of CVD
  
 X
 X
Current medication
  
  
 X
Recent hospital admissions
  
  
 X
Gestational diabetes (women only)
 X
 X
 X
Lifestyle behaviours (smoking, alcohol consumption, physical activity)
  
 X
 X
Current weight, birth weight, weight loss/gain, perceived body image
  
  
 X
EuroQol 5-D (health utility)
  
  
 X
SF-36 (functional status)
  
  
 X
Registry information
  
  
 X
Cardiovascular disease
 X
 X
 X
Type 2 diabetes
 X
 X
 X
Medication use
 X
 X
 X
Health service use
 X
 X
 X
Mortality     X

1 Low diabetes risk <5 points on the diabetes risk score.

2 High diabetes risk ≥5 points on the diabetes risk score.

3 At screening, only for individuals with elevated RBG/FBG levels who progressed through to the later stages of the screening programme.

4 At ADDITION-PRO, only for individuals without incident diabetes since screening.

5 Only collected at the Steno Diabetes Center.

6 Only collected at the Steno Diabetes Center and in Aarhus.

7 Collected at the Steno Diabetes Center, Esbjerg and Aarhus from July 2010.